USP36
Basic information
Region (hg38): 17:78787381-78841441
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP36 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 74 | 10 | 88 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 74 | 16 | 10 |
Variants in USP36
This is a list of pathogenic ClinVar variants found in the USP36 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-78798428-G-A | not specified | Uncertain significance (Dec 07, 2023) | ||
17-78798455-G-C | not specified | Uncertain significance (Jan 04, 2022) | ||
17-78798498-G-C | not specified | Uncertain significance (Mar 25, 2024) | ||
17-78798504-G-A | Benign (May 09, 2018) | |||
17-78798546-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
17-78798958-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
17-78799711-T-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-78799729-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
17-78802329-C-T | not specified | Likely benign (Mar 07, 2024) | ||
17-78802363-C-T | not specified | Likely benign (Feb 14, 2023) | ||
17-78802376-C-G | not specified | Uncertain significance (Jul 30, 2023) | ||
17-78802419-T-C | not specified | Uncertain significance (Jun 30, 2022) | ||
17-78802423-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
17-78802441-C-A | not specified | Uncertain significance (Jun 26, 2023) | ||
17-78803401-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
17-78803416-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
17-78803431-C-A | not specified | Uncertain significance (Oct 17, 2023) | ||
17-78803494-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
17-78803535-C-G | Benign (Jul 31, 2018) | |||
17-78803622-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-78803644-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
17-78803647-T-G | not specified | Uncertain significance (Jan 03, 2024) | ||
17-78803655-T-C | not specified | Likely benign (Dec 16, 2023) | ||
17-78803684-A-G | Likely benign (Apr 01, 2022) | |||
17-78803748-A-G | not specified | Uncertain significance (Mar 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP36 | protein_coding | protein_coding | ENST00000542802 | 18 | 54061 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000188 | 1.00 | 125706 | 0 | 42 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.398 | 720 | 691 | 1.04 | 0.0000425 | 7306 |
Missense in Polyphen | 204 | 248.31 | 0.82155 | 2720 | ||
Synonymous | -1.40 | 316 | 286 | 1.11 | 0.0000193 | 2238 |
Loss of Function | 4.35 | 18 | 51.8 | 0.347 | 0.00000278 | 576 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000274 | 0.000273 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinase essential for the regulation of nucleolar structure and function. Required for cell and organism viability. Plays an important role in ribosomal RNA processing and protein synthesis, which is mediated, at least in part, through deubiquitination of DHX33, NPM1 and FBL, regulating their protein stability (PubMed:29273634, PubMed:19208757, PubMed:22902402). Function as a transcriptional repressor by deubiquiting histone H2B at the promoters of genes critical for cellular differentiation, such as CDKN1A, thereby preventing histone H3 'Lys-4' trimethylation (H3K4) (PubMed:29274341). Specifically deubiquitinates MYC in the nucleolus, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 3 of FBXW7 (FBW7gamma) in the nucleolus and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm (PubMed:25775507). Interacts to and regulates the actions of E3 ubiquitin-protein ligase NEDD4L over substrates such as NTRK1, KCNQ2 and KCNQ3, affecting their expression an functions (PubMed:27445338). Deubiquitinates SOD2, regulates SOD2 protein stability (PubMed:21268071). Deubiquitinase activity is required to control selective autophagy activation by ubiquitinated proteins (PubMed:22622177). {ECO:0000269|PubMed:19208757, ECO:0000269|PubMed:21268071, ECO:0000269|PubMed:22622177, ECO:0000269|PubMed:22902402, ECO:0000269|PubMed:25775507, ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:29273634, ECO:0000269|PubMed:29274341}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.637
- rvis_EVS
- 2.11
- rvis_percentile_EVS
- 97.9
Haploinsufficiency Scores
- pHI
- 0.0950
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.885
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp36
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; skeleton phenotype;
Zebrafish Information Network
- Gene name
- usp36
- Affected structure
- pharyngeal arch cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;nucleolus organization;negative regulation of macroautophagy;histone deubiquitination;protein deubiquitination;regulation of protein stability;regulation of apoptotic process;protein stabilization;regulation of autophagy of mitochondrion;positive regulation of protein targeting to mitochondrion;regulation of rRNA processing
- Cellular component
- nucleolus;cytoplasm;nuclear speck
- Molecular function
- RNA binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding